Stem cell transplantation in systemic lupus erythematosus

Best Practice and Research: Clinical Haematology

Volumn 17, Issue 2, 2004, Pages 291-304

  Jayne, David ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cyclophosphamide; Haematopoietic stem cell transplantation; Immunoablation; Nephritis; Systemic lupus erythematosus; Therapy

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BUSULFAN; CD34 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOUBLE STRANDED DNA; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LJP 694; MELPHALAN; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

AMENORRHEA; BONE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RESPONSE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REMISSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOGENICITY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 4344653636     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2004.05.001     Document Type: Article

References (69)

1. Prokunina L. Alarcon-Riquelme M. The genetic basis of systemic lupus erythematosus-knowledge of today and thoughts for tomorrow Human Molecular Genetics 13 Special Number 1 2004 R143-R148
2. Manderson A.P. Botto M. Walport M.J. The role of complement in the development of systemic lupus erythematosus Annual Review of Immunology 22 2004 431-456
3. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis and Rheumatism 40 1997 1725
4. Weening J.J. D'Agati V.D. Schwartz M.M. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited Journal of the American Society of Nephrology 15 2004 241-250
5. Schwartz M.M. Bernstein J. Hill G.S. Holley K. Phillips E.A. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group Kidney International 36 1989 891-896
6. Donadio J.V. Jr. Hart G.M. Bergstralh E.J. Holley K.E. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study Lupus 4 1995 109-115
7. Strand V. Gladman D. Isenberg D. Petri M. Smolen J. Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Outcome measures in rheumatology Lupus 9 2000 322-327
8. Bombardieri C. Gladman D.D. Urowitz M.B. Caron D. Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis and Rheumatism 35 1992 630-640
9. Isenberg D.A. Gordon C. From BILAG to BLIPS - disease activity assessment in lupus past, present and future Lupus 9 2000 651-654
10. Brunner H.I. Feldman B.M. Urowitz M.B. Gladman D.D. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement Journal of Rheumatology 30 2003 292-297
11. Austin H.A. Balow J.E. Treatment of lupus nephritis Seminars in Nephrology 20 2000 265-276
12. Bansal V.K. Beto J.A. Treatment of lupus nephritis: a meta-analysis of clinical trials American Journal of Kidney Disease 29 1997 193-199
13. Chan T.M. Li F.K. Tang C.S. et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group New England Journal of Medicine 343 2000 1156-1162
14. Bono L. Cameron J.S. Hicks J.A. The very long-term prognosis and complications of lupus nephritis and its treatment Quarterly Journal of Medicine 92 1999 211-218
15. Boumpas D.T. Austin H.A. Vaughan E.M. et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy Annals of Internal Medicine 119 1993 366-369
16. Bellomio V. Spindler A. Lucero E. et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study Lupus 9 2000 377-381
17. Trager J. Ward M.M. Mortality and causes of death in systemic lupus erythematosus Current Opinion in Rheumatology 13 2001 345-351
18. Korbet S.M. Lewis E.J. Schwartz M.M. et al. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group American Journal of Kidney Disease 35 2000 904-914
19. Cook R.J. Gladman D.D. Pericak D. Urowitz M.B. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity Journal of Rheumatology 27 2000 1892-1895
20. Moroni G. Quaglini S. Maccario M. Banfi G. Ponticelli C. Nephritic flares are predictors of bad long-term renal outcome in lupus nephritis Kidney International 50 1996 2047-2053
21. Sultan S.M. Ioannou Y. Isenberg D.A. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review Rheumatology (Oxford) 39 2000 1147-1152
22. Hahn B.H. Systemic lupus erythematosus and accelerated atherosclerosis New England Journal of Medicine 349 2003 2379-2380
23. Wallace D.J. Apheresis for lupus erythematosus: state of the art Lupus 10 2001 193-196
24. Boletis J.N. Ioannidis J.P. Boki K.A. Moutsopoulos H.M. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis Lancet 354 1999 569-570
25. Davis J.C. Jr. Austin H.I.I.I. Boumpas D. et al. A pilot study of 2-chloro-2′-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis Arthritis and Rheumatism 412 1998 335-343
26. Leitman S.F. Tisdale J.F. Bolan C.D. et al. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus Transfusion 43 2003 1667-1671
27. Favalli E.G. Sinigaglia L. Varenna M. Arnoldi C. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis Lupus 11 2002 753-755
28. Boumpas D.T. Furie R. Manzi S. et al. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis Arthritis and Rheumatism 48 2003 719-727
29. Toubi E. Shoenfeld Y. BLyS/BAFF: a potential target in the treatment of active systemic lupus erythematosus Israel Medical Association Journal 6 2004 99-102
30. Alarcon-Segovia D. Tumlin J.A. Furie R.A. et al. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study Arthritis and Rheumatism 48 2003 442-454
31. Anolik J.H. Campbell D. Felgar R.E. et al. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus Arthritis and Rheumatism 48 2003 455-459
32. Leandro M.J. Edwards J.C. Cambridge G. Ehrenstein M.R. Isenberg D.A. An open study of B lymphocyte depletion in systemic lupus erythematosus Arthritis and Rheumatism 46 2002 2673-2677
33. Liu H. Ozaki K. Matsuzaki Y. et al. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE) Clinical and Experimental Immunology 100 1995 480-485
34. Marques J.A. Rhim H. Distenfeld A. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus Puerto Rico Health Sciences Journal 14 1995 293-296
35. Papadaki H.A. Boumpas D.T. Gibson F.M. et al. Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus British Journal of Haematology 115 2001 167-174
36. Papadaki H.A. Autoreactive T-lymphocytes are implicated in the pathogenesis of bone marrow failure in patients with systemic lupus erythematosus Leukemia and Lymphoma 44 2003 1301-1307
37. Shaughnessy P.J. Ririe D.W. Ornstein D.L. et al. Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue Bone Marrow Transplantation 27 2001 221-224
38. Meloni G. Capria S. Vignetti M. Mandelli F. Modena V. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation Blood 89 1997 4659
39. Schachna L. Ryan P.F. Schwarer A.P. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation Arthritis and Rheumatism 41 1998 2271-2272
40. Passweg J. Gratwohl A. Tyndall A. Hematopoietic stem cell transplantation for autoimmune disorders Current Opinion in Hematology 6 1999 400-405
41. Petri M. Jones R.J. Brodsky R.A. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus Arthritis and Rheumatism 48 2003 166-173
42. Jayne D.R.W. Passweg J. Marmont A. Farge D. Zhao X. Arnold R. et al. Autologous stem cell transplantation for systemic lupus erythematosus Lupus 13 2004 168-176
43. Traynor A.E. Barr W.G. Rosa R.M. et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients Arthritis and Rheumatism 46 2002 2917-2923
44. Hashimoto N. Iwasaki T. Sekiguchi M. et al. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis Bone Marrow Transplantation 33 2004 863-866
45. Steinbach W.J. Sandborg C.I. Development of systemic lupus erythematosus following autologous bone marrow transplant for acute lymphocytic leukemia Journal of Rheumatology 28 2001 1467-1468
46. Coles A.J. Wing M. Smith S. et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis Lancet 354 1999 1691-1695
47. Euler H.H. Marmont A.M. Bacigalupo A. et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation Blood 88 1996 3621-3625
48. Rosen O. Hiepe F. Massenkeil G. et al Relapse of systemic lupus erythematosus Lancet 357 2001 807-808
49. Marmont A.M. Hematopoietic stem cell transplantation for severe and refractory lupus: comment on the article by Traynor et al Arthritis and Rheumatism 48 2003 2696-2697
50. Pavletic S.Z. Klassen L.W. Pope R. et al. Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis Journal of Rheumatology Supplement 64 2001 28-31
51. Moore J. Brooks P. Milliken S. et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis Arthritis and Rheumatism 46 2002 2301-2309
52. El Badri N.S. Wang B.Y. Steele A. et al Successful prevention of autoimmune disease by transplantation of adequate number of fully allogeneic hematopoietic stem cells Transplantation 70 870 2000 877
53. Marmont A.M. Gualandi F. van Lint M.T. Bacigalupo A. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect Bone Marrow Transplantation 31 2003 399-402
54. Hinterberger W. Hinterberger-Fischer M. Marmont A. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases Bone Marrow Transplantation 30 2002 753-759
55. Burt R.K. Marmont A. Arnold R. et al. Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus Bone Marrow Transplantation 32 supplement 1 2003 S49-S51
56. Ishida T. Inaba M. Hisha H. et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same dono Journal of Immunology 152 1994 3119-3127
57. Blank M. Tomer Y. Slavin S. Shoenfeld Y. Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation Scandinavian Journal of Immunology 42 1995 226-234
58. Petry F. Botto M. Holtappels R. Walport M.J. Loos M. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells Journal of Immunology 167 2001 4033-4037
59. Bao L. Haas M. Boackle S.A. et al. Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice Journal of Immunology 168 2002 3601-3607
60. Marmont A.M. van Lint M.T. Gualandi F. Bacigalupo A. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration Lupus 6 1997 545-548
61. Musso M. Porretto F. Crescimanno A. et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome Lupus 7 1998 492-494
62. Fouillard L. Gorin N.C. Laporte J.P. et al. Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood Lupus 8 1999 320-323
63. Trysberg E. Lindgren I. Tarkowski A. Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus Annals of the Rheumatic Diseases 59 2000 236-238
64. Rosen O. Thiel A. Massenkeil G. et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells Arthritis Research 2 2000 327-336
65. Wulffraat N.M. Sanders E.A. Kamphuis S.S. et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus Arthritis and Rheumatism 44 2001 728-731
66. Brunner M. Greinix H.T. Redlich K. et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report Arthritis and Rheumatism 46 2002 1580-1584
67. Lisukov I.A. Sizikova S.A. Kulagin A.D. et al. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus Lupus 13 2004 89-94
68. Chen J. Gu L.J. Zhao H.J. et al. Application of CD34+ autologous peripheral progenitor cell transplant in the treatment of children with refractory SLE Zhonghua Er Ke Za Zhi 41 2003 426-429
69. Austin H.A.I.I.I. Muenz L.R. Joyce K.M. et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome Kidney International 25 1984 689-695